|
1
|
Eley JW, Hill HA, Chen VW, Austin DF,
Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK,
et al: Racial differences in survival from breast cancer: Results
of the National cancer institute black/white cancer survival study.
JAMA. 272:947–954. 1994.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Neale AV: Racial and marital status
influences on 10 year survival from breast cancer. J Clin
Epidemiol. 47:475–483. 1994.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Simon MS and Severson RK: Racial
differences in survival of female breast cancer in the Detroit
metropolitan area. Cancer. 77:308–314. 1996.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Howard DL, Penchansky R and Brown MB:
Disaggregating the effects of race on breast cancer survival. Fam
Med. 30:228–235. 1998.PubMed/NCBI
|
|
5
|
Yood MU, Johnson CC, Blount A, Abrams J,
Wolman E, McCarthy BD, Raju U, Nathanson DS, Worsham M and Wolman
SR: Race and differences in breast cancer survival in a managed
care population. J Natl Cancer Inst. 91:1487–1491. 1999.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bradley CJ, Given CW and Roberts C: Race,
socioeconomic status, and breast cancer treatment and survival. J
Natl Cancer Inst. 94:490–496. 2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mandelblatt JS, Kerner JF, Hadley J, Hwang
YT, Eggert L, Johnson LE and Gold K: OPTIONS (Outcomes and
Preferences for Treatment in Older Women Nationwide Study).
Variations in breast carcinoma treatment in older Medicare
beneficiaries: Is it black or white? Cancer. 95:1401–1414.
2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ward E, Jemal A, Cokkinides V, Singh GK,
Cardinez C, Ghafoor A and Thun M: Cancer disparities by
race/ethnicity and socioeconomic status. CA Cancer J Clin.
54:78–93. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Daly B and Olopade OI: A perfect storm:
How tumor biology, genomics, and health care delivery patterns
collide to create a racial survival disparity in breast cancer and
proposed interventions for change. CA Cancer J Clin. 65:221–238.
2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Iqbal J, Ginsburg O, Rochon PA, Sun P and
Narod SA: Differences in breast cancer stage at diagnosis and
cancer-specific survival by race and ethnicity in the United
States. JAMA. 313:165–173. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Daly B and Olopade OI: Race, ethnicity,
and the diagnosis of breast cancer. JAMA. 313:141–142.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Amini A, Jones BL, Yeh N, Guntupalli SR,
Kavanagh BD, Karam SD and Fisher CM: Disparities in disease
presentation in the four screenable cancers according to health
insurance status. Public Health. 138:50–56. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jemal A, Lin CC, Davidoff AJ and Han X:
Changes in insurance coverage and stage at diagnosis among
nonelderly patients with cancer after the affordable care act. J
Clin Oncol. 35:3906–3915. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ko NY, Hong S, Winn RA and Calip GS:
Association of Insurance status and racial disparities with the
detection of early-stage breast cancer. JAMA Oncol. 6:385–392.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948.
2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cunningham JE, Montero AJ, Garrett-Mayer
E, Berkel HJ and Ely B: Racial differences in the incidence of
breast cancer subtypes defined by combined histologic grade and
hormone receptor status. Cancer Causes Control. 21:399–409.
2010.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Howlader N, Altekruse SF, Li CI, Chen VW,
Clarke CA, Ries LA and Cronin KA: US incidence of breast cancer
subtypes defined by joint hormone receptor and HER2 status. J Natl
Cancer Inst. 106(dju055)2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen L and Li CI: Racial disparities in
breast cancer diagnosis and treatment by hormone receptor and HER2
status. Cancer Epidemiol Biomarkers Prev. 24:1666–1672.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Newman LA and Kaljee LM: Health
disparities and triple-negative breast cancer in African American
women: A review. JAMA Surg. 152:485–493. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Siddharth S and Sharma D: Racial disparity
and triple-negative breast cancer in African-American women: A
multifaceted affair between obesity, biology, and socioeconomic
determinants. Cancers (Basel). 10(514)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Garlapati C, Joshi S, Sahoo B, Kapoor S
and Aneja R: The persisting puzzle of racial disparity in
triple-negative breast cancer: Looking through a new lens. Front
Biosci (Schol Ed). 11:75–88. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Kong X, Liu Z, Cheng R, Sun L, Huang S,
Fang Y and Wang J: Variation in breast cancer subtype incidence and
distribution by race/ethnicity in the United States From 2010 to
2015. JAMA Netw Open. 3(e2020303)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Tao L, Gomez SL, Keegan TH, Kurian AW and
Clarke CA: Breast cancer mortality in African-American and
non-Hispanic white women by molecular subtype and stage at
diagnosis: A population-based study. Cancer Epidemiol Biomarkers
Prev. 24:1039–1045. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Brinton LA, Figueroa JD, Awuah B, Yarney
J, Wiafe S, Wood SN, Ansong D, Nyarko K, Wiafe-Addai B and
Clegg-Lamptey JN: Breast cancer in Sub-Saharan Africa:
Opportunities for prevention. Breast Cancer Res Treat. 144:467–478.
2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Prakash O, Hossain F, Danos D, Lassak A,
Scribner R and Miele L: Racial disparities in triple-negative
breast cancer: A review of the role of biologic and non-biologic
factors. Front Public Health. 8(576964)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Dawood S, Broglio K, Kau SW, Green MC,
Giordano SH, Meric-Bernstam F, Buchholz TA, Albarracin C, Yang WT,
Hennessy BT, et al: Triple receptor-negative breast cancer: The
effect of race on response to primary systemic treatment and
survival outcomes. J Clin Oncol. 27:220–226. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dean-Colomb W, Yan K, Liedtke C, Symmans
WF, Holmes FA, O'Shaughnessy J, Asmar L, Hortobagyi GN, Pusztai L
and Gonzalez-Angulo AM: Transcriptional profiles of triple
receptor-negative breast cancer: Are Caucasian, Hispanic, and
African-American women different? J Clin Oncol. 26
(Suppl)(S22014)2008.
|
|
28
|
Lund MJ, Trivers KF, Porter PL, Coates RJ,
Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG and
Eley JW: Race and triple negative threats to breast cancer
survival: A population-based study in Atlanta, GA. Breast Cancer
Res Treat. 113:357–370. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bauer KR, Brown M, Cress RD, Parise CA and
Caggiano V: Descriptive analysis of estrogen receptor
(ER)-negative, progesterone receptor (PR)-negative, and
HER2-negative invasive breast cancer, the so-called triple-negative
phenotype: A population-based study from the California cancer
registry. Cancer. 109:1721–1728. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li X, Yang J, Peng L, Sahin AA, Huo L,
Ward KC, O'Regan R, Torres MA and Meisel JL: Triple-negative breast
cancer has worse overall survival and cause-specific survival than
non-triple-negative breast cancer. Breast Cancer Res Treat.
161:279–287. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
National Cancer Institute (NCI),
Surveillance Epidemiology, End Results (SEER) Program: SEER*Stat
Database: Incidence - SEER Research Data, Nov 2018 Sub (1975-2016)
<Katrina/Rita Population Adjustment> - Linked To County
Attributes - Total U.S., 1969-2017 Counties, National Cancer
Institute, DCCPS, Surveillance Research Program, released April.
2019, based on the November 2018 submission. NCI, Bethesda, MD,
2018.
|
|
32
|
Gershuni V, Li YR, Williams AD, So A,
Steel L, Carrigan E and Tchou J: Breast cancer subtype distribution
is different in normal weight, overweight, and obese women. Breast
Cancer Res Treat. 163:375–381. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pierobon M and Frankenfeld CL: Obesity as
a risk factor for triple-negative breast cancers: A systematic
review and meta-analysis. Breast Cancer Res Treat. 137:307–314.
2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Plasilova ML, Hayse B, Killelea BK,
Horowitz NR, Chagpar AB and Lannin DR: Features of triple-negative
breast cancer: Analysis of 38,813 cases from the national cancer
database. Medicine (Baltimore). 95(e4614)2016.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Dietze EC, Sistrunk C, Miranda-Carboni G,
O'Regan R and Seewaldt VL: Triple-negative breast cancer in
African-American women: Disparities versus biology. Nat Rev Cancer.
15:248–254. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
37
|
Jiralerspong S and Goodwin PJ: Obesity and
breast cancer prognosis: Evidence, challenges, and opportunities. J
Clin Oncol. 34:4203–4216. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Dietze EC, Chavez TA and Seewaldt VL:
Obesity and triple-negative breast cancer: Disparities,
controversies, and biology. Am J Pathol. 188:280–290.
2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Naik A, Monjazeb AM and Decock J: The
obesity paradox in cancer, tumor immunology, and immunotherapy:
Potential therapeutic implications in triple negative breast
cancer. Front Immunol. 10(1940)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Rose DP, Gracheck PJ and Vona-Davis L: The
interactions of obesity, inflammation and insulin resistance in
breast cancer. Cancers (Basel). 7:2147–2168. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Vona-Davis L and Rose DP: The influence of
socioeconomic disparities on breast cancer tumor biology and
prognosis: A review. J Womens Health (Larchmt). 18:883–893.
2009.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Danforth DN Jr: Disparities in breast
cancer outcomes between Caucasian and African American women: A
model for describing the relationship of biological and
nonbiological factors. Breast Cancer Res. 15(208)2013.PubMed/NCBI View
Article : Google Scholar
|
|
43
|
Carey LA, Perou CM, Livasy CA, Dressler
LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S,
et al: Race, breast cancer subtypes, and survival in the Carolina
breast cancer study. JAMA. 295:2492–2502. 2006.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Institute of Medicine (US) Committee on
Understanding and Eliminating Racial and Ethnic Disparities in
Health Care: Unequal Treatment: Confronting Racial and Ethnic
Disparities in Health Care. Smedley BD, Stith AY and Nelson ΑΡ
(eds). National Academy Press, Washington, DC, 2002.
|
|
45
|
Bustos MA, Salomon MP, Nelson N, Hsu SC,
DiNome ML, Hoon DS and Marzese DM: Genome-wide chromatin
accessibility, DNA methylation and gene expression analysis of
histone deacetylase inhibition in triple-negative breast cancer.
Genom Data. 12:14–16. 2017.PubMed/NCBI View Article : Google Scholar
|
